Kinetic profiling of P-glycoprotein-mediated drug efflux in rat and human intestinal epithelia

Journal of Pharmacology and Experimental Therapeutics

Volumn 296, Issue 2, 2001, Pages 584-591

  Stephens, R H ^a   O'Neill, C A ^a   Warhurst, A ^a   Carlson, G L ^a   Rowland, M ^a   Warhurst, G ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; DIGOXIN; GLYCOPROTEIN; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN; VERAPAMIL;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CELL STRAIN CACO 2; COLON; CONTROLLED STUDY; DRUG PROTEIN BINDING; DRUG TRANSPORT; EFFUSION; HUMAN; HUMAN TISSUE; ILEUM; IN VITRO STUDY; INTESTINE ABSORPTION; JEJUNUM; MULTIDRUG RESISTANCE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CACO-2 CELLS; CALCIUM CHANNEL BLOCKERS; CARDIOTONIC AGENTS; COLONIC NEOPLASMS; DIGOXIN; DNA PRIMERS; EPITHELIUM; GLYCOPROTEINS; HUMANS; INTESTINAL MUCOSA; KINETICS; MALE; P-GLYCOPROTEIN; PHARMACEUTICAL PREPARATIONS; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VERAPAMIL; VINBLASTINE;

EID: 0035146553     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelia
2. Transport and epithelial secretion of the cardiac glycoside, digoxin, by human intestinal epithelial (Caco-2) cells
3. Modulation of the permeability of H2 receptor antagonists cimetidine and ranitidine by P-glycoprotein in rat intestine and the human colonic cell line Caco-2
4. Comparison of HT29-18-C1 and Caco-2 cell lines as models for studying intestinal paracellular drug absorption
5. Function, evolution and structure of multidrug resistance protein (MRP)
6. The MDR1 gene product, P-glycoprotein, mediates the transport of the cardiac glycoside, digoxin
7. Radioligand-binding assay employing P-glycoprotein-overexpressing cells: Testing drug affinities to the secretory intestinal multidrug transporter
8. Role of P-glycoprotein-mediated secretion in absorptive drug permeability: An approach using passive membrane permeability and affinity to P-glycoprotein
9. Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA
10. Basolateral localisation and export activity of the human multidrug resistance-associated protein in polarised pig kidney cells
11. Inhibition of P-glycoprotein-mediated drug transport - A unifying mechanism to explain the interaction between digoxin and quinidine
12. Applications of the Caco-2 model in the design and development of orally active drugs: Elucidation of biochemical and physical barriers posed by the intestinal epithelium
13. Involvement of an organic anion transporter (canalicular multispecific organic anion transporter/multidrug resistance-associated protein 2) in gastrointestinal secretion of glutathione conjugates in rats
14. Function and expression of multidrug resistance-associated protein family in human colon adenocarcinoma cells (Caco-2)
15. Transport properties of the multidrug resistance-associated protein (MRP) in human tumour cells
16. Transepithelial transport of drugs by the multidrug transporter in cultured Madin-Darby canine kidney epithelia
17. Transepithelial transport of vinblastine by kidney-derived cell lines. Application of a new kinetic model to estimate in situ Km of the pump
18. Intestinal secretion of drugs. The role of P-glycoprotein and related drug efflux systems in limiting oral drug absorption
19. Drug absorption limited by P-glycoprotein-mediated secretory drug transport in human intestinal epithelial Caco-2 cell layers
20. Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells. Kinetics of vinblastine secretion and interaction with modulators
21. Energy-dependent transport of digoxin across renal tubular cell monolayers (LLC-PK1)
22. The mechanism of the verapamil-digoxin interaction in renal tubular cells (LLC-PK1)
23. Modeling of P-glycoprotein-involved epithelial drug transport in MDCK cells
24. Inter-relationship between substrates and inhibitors of human CYP3A and P-glycoprotein
25. Characterization and regional intestinal kinetics of drug efflux in rat and human intestine and Caco-2 cells
26. ATP-dependent uptake of natural product cytotoxic drugs by membrane vesicles establishes MRP as a broad specificity transporter
27. Evidence that the multidrug resistance protein (MRP) functions as a co-transporter of glutathione and natural product toxins
28. Possible involvement of multiple P-glycoprotein-mediated efflux systems in the transport of verapamil and other organic cations across rat intestine
29. Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line
30. Active secretion of drugs from the small intestinal epithelium in rats by P-glycoprotein functioning as an absorption barrier
31. Experimental modulation of MRP (multidrug resistance-associated protein)-mediated resistance
32. Assessment of drug-induced dysregulations among seven resistance-associated genes in human tumour cell lines
33. On the relationship between the probenicid-sensitive transport of daunorubicin or calcein and the glutathione status of cells overexpressing the multidrug resistance associated protein (MRP)
34. Somatostatin receptor subtype 2 mediates somatostatin inhibition of ion secretion in rat distal colon
35. The barrier function of CYP3A4 and P-glycoprotein in the small bowel
36. Polarized transport of docetaxel and vinblastine mediated by P-glycoprotein in human intestinal epithelial cell monolayers
37. The digoxin-propafenone interaction: Characterisation of a mechanism using renal tubular cell monolayers
38. Analysis of drug permeation across Caco-2 monolayer: Implications for predicting in vivo drug absorption
39. In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man-fact or myth